Skip to main content
. 2022 May 18;78:103822. doi: 10.1016/j.amsu.2022.103822

Table 3.

Histopathological result and molecular status of metaplastic breast carcinoma.

No. of patients,
n = 14, n(%)
Histological subtype Squamous cell carcinoma 6 (42.9%)
Spindle cell carcinoma 2 (14.3%)
Metaplastic carcinoma with mesenchymal differentiation 1 (7.1%)
Metaplastic carcinoma of no specific type 5 (35.7%)



Molecular Status ER (+) PR/HER2 (−) 2 (14.3%)
ER/PR (+) HER2 (−) 1 (7.1%)
ER/PR (−) HER2 (+) 1 (7.1%)
Triple negative 10 (71.4%)